Clene Receives $3 Million Loan from State of Maryland to Support Development of Commercial Manufacturing Facility
Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company...
Read more